Opsoclonus-Myoclonus Syndrome

Opsoclonus-Myoclonus Syndrome (OMS) is a rare inflammatory neurological disorder characterized by ocular, sleep, and behavioural disorders, as well as ataxia. Here is the latest research on OMS.

September 12, 2021

Atypical Presentation of Enterovirus D68 Infection as Opsoclonus-Myoclonus Syndrome.

Pediatric Neurology
Matthew J Martin, Sean C Rose
September 3, 2021

Increased Prevalence of Familial Autoimmune Disease in Children With Opsoclonus-Myoclonus Syndrome.

Neurology. Neuroimmunology and Neuroinflammation
Jonathan D SantoroMark P Gorman
September 2, 2021

Acute Movement Disorders in Childhood: A Cohort Study and Review of the Literature.

Pediatric Emergency Care
Hanene BenrhoumaIlhem Turki
August 21, 2021

Delayed Opsoclonus-Myoclonus Syndrome After Ovarian Teratoma Resection.

Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society
Andrea A Jones, Tychicus Chen
August 6, 2021

Scrub typhus meningoencephalitis presenting as opsoclonus myoclonus syndrome: A video-based case.

Tropical Doctor
Laxmikant Ramkumarsingh TomarC S Agrawal
July 20, 2021
Review
Open Access

New-Onset Movement Disorders Associated with COVID-19.

Tremor and Other Hyperkinetic Movements
Pedro Renato P BrandãoFrancisco Cardoso
July 20, 2021
Review
Open Access

Paraneoplastic neurological syndrome: an evolving story.

Neuro-oncology Practice
Jiraporn JitprapaikulsanDivyanshu Dubey
July 17, 2021

Opsoclonus in Uremia With Resolution After Hemodialysis.

Journal of Neuro-ophthalmology : the Official Journal of the North American Neuro-Ophthalmology Society
Abhinav R ChangaPatrick S Drummond
July 10, 2021

Opsoclonus myoclonus induced by lamotrigine toxicity.

Seizure : the Journal of the British Epilepsy Association
Rania ZouariChahnez Triki
June 26, 2021
Case Report

Recurrent angiosarcoma of scalp with opsoclonus myoclonus syndrome: role of salvage treatment.

BMJ Case Reports
Kannan PeriasamyRakesh Kapoor
June 24, 2021
Case Report
Open Access

Post-COVID Opsoclonus Myoclonus Syndrome: A Case Report From Pakistan.

Frontiers in Neurology
Hira IshaqMian Ayaz Ul Haq
June 22, 2021

Opsoclonus-myoclonus in Aicardi-Goutières syndrome.

Developmental Medicine and Child Neurology
Salam AlburaikyCynthia Sharpe
June 8, 2021
Open Access

Two COVID-19-related video-accompanied cases of severe ataxia-myoclonus syndrome.

Neurologia i neurochirurgia polska
Filip PrzytułaJarosław Sławek
May 29, 2021
Case Report
Open Access

78-year-old woman with opsoclonus myoclonus ataxia syndrome secondary to COVID-19.

BMJ Case Reports
Biplab SahaWoon Hean Chong

Sign up to follow this feed and discover related papers.

Related Feeds

3D Cellular Models of Brain and Neurodegeneration

Brain organoids are three-dimensional in vitro cellular models of the brain that can recapitulate many processes such as the neurodevelopment. In addition, these organoids can be combined with other cell types, such as neurons and astrocytes to study their interactions in assembloids. Disease processes can also be modeled by induced pluripotent stem cell-derived organoids and assembloids from patients with neurodegenerative disorders. Discover the latest research on the models here.

ALS & FTD: TDP-43

TAR DNA-binding protein 43 (TDP-43) is a pathological protein identified in sporadic Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). Here are the latest discoveries pertaining to TDP-43 and these diseases.

ALS: Genetics

Amyotrophic Lateral Sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS: Phenotypes

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disorder characterized phenotypically by progressive muscle weakness. Clinical phenotypes of ALS can be classified based on the pattern, level, and area of onset (e.g. bulbar, cervical, lumbar). Here is the latest research investigating phenotypes of ALS.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here is the latest research on ALS and prions.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research in this field.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS) is associated with the death of neurons that control voluntary muscles. This feed followes the latest research into therapies for this progressive neurodegenerative disease.

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.

Age-related Dementia

Dementias are a group of conditions, including Alzheimer's disease, vascular dementia, and frontotemporal dementia, characterized by deficiencies in cognitive abilities. Age-related dementia refers to dementias that occur in older individuals, usually 60+ years old, in contrast to early-onset dementia. Follow the latest research on age-related dementia here.

© 2021 Meta ULC. All rights reserved
/feed-previews/opsoclonus-myoclonus-syndrome/adf784a9-d144-44a6-9c4c-53ce17a8e755